Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older.
- People who have been diagnosed with an anxiety disorder under DSM-5 criteria — specifically specific phobia, agoraphobia, panic disorder, or social phobia.
- People who are willing to follow the conditions of the study.
- People who are willing to sign a consent form.
Who may not be able to join:
- People who have another psychological problem that needs immediate treatment.
- People who currently have alcohol or drug dependence or misuse, psychosis, or a severe physical illness.
- People who are currently taking part in a similar treatment program.
- People who are taking anti-anxiety medications during the study period, or who change their medication or dose while the study is ongoing.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Juana María Bretón-López, Lecturer, University Jaume I
Phone: +34 964 38 76 51
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Anxiety Disorders Interview Schedule for DSM-IV-TR (ADIS-IV); Fear and avoidance scales
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.